Denali Therapeutics Inc. SEC filings DNLI

Denali Therapeutics Inc. has 789 filings in SEC EDGAR's recent list, going back to Sep 8, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Denali Therapeutics Inc. SEC filings
Form Description Filed Period
4 Insider transaction Sep 9, 2026 Sep 4, 2026
144 Notice of proposed sale Sep 4, 2026 —
4 Insider transaction Sep 4, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 4, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 8, 2026 —
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
3/A Form 3/a Apr 21, 2026 Apr 10, 2026
3 Initial insider ownership Apr 20, 2026 Apr 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
144 Notice of proposed sale Feb 5, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 5, 2026 Jan 3, 2026
4 Insider transaction Jan 5, 2026 Jan 3, 2026
4 Insider transaction Dec 15, 2025 Dec 11, 2025
144 Notice of proposed sale Dec 4, 2025 —
4 Insider transaction Nov 6, 2025 Nov 4, 2025
3 Initial insider ownership Nov 6, 2025 Nov 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Sep 5, 2025 Sep 3, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
4 Insider transaction Aug 7, 2025 Aug 5, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
144 Notice of proposed sale Jul 9, 2025 —
4 Insider transaction Jun 5, 2025 Jun 3, 2025
3 Initial insider ownership Jun 5, 2025 Jun 3, 2025
3 Initial insider ownership Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Jan 8, 2025 Jan 6, 2025
4 Insider transaction Jan 8, 2025 Jan 6, 2025
4 Insider transaction Jan 8, 2025 Jan 6, 2025
4 Insider transaction Jan 8, 2025 Jan 7, 2025
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 2, 2025 —
4 Insider transaction Dec 31, 2024 Dec 27, 2024
144 Notice of proposed sale Dec 31, 2024 —
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 26, 2024 Nov 22, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
SC 13G Ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2024 —
144 Notice of proposed sale Nov 7, 2024 —
4 Insider transaction Nov 5, 2024 Nov 1, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 21, 2024 —
144 Notice of proposed sale Oct 18, 2024 —
4 Insider transaction Oct 2, 2024 Sep 30, 2024
144 Notice of proposed sale Sep 30, 2024 —
4 Insider transaction Sep 16, 2024 Sep 13, 2024
144 Notice of proposed sale Sep 13, 2024 —
4 Insider transaction Sep 4, 2024 Sep 3, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
144 Notice of proposed sale Aug 21, 2024 —
144 Notice of proposed sale Aug 21, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
SC 13G Ownership over 5% (passive) Aug 16, 2024 —
4 Insider transaction Aug 15, 2024 Aug 13, 2024
4 Insider transaction Aug 15, 2024 Aug 13, 2024
144 Notice of proposed sale Aug 13, 2024 —
144 Notice of proposed sale Aug 13, 2024 —
4 Insider transaction Jul 3, 2024 Jun 13, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
144 Notice of proposed sale Jul 1, 2024 —
144 Notice of proposed sale Jul 1, 2024 —
4 Insider transaction Jun 10, 2024 Jun 6, 2024
144 Notice of proposed sale Jun 6, 2024 —
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction Apr 17, 2024 Apr 15, 2024
144 Notice of proposed sale Apr 15, 2024 —
4 Insider transaction Apr 2, 2024 Apr 1, 2024
144 Notice of proposed sale Apr 1, 2024 —
4 Insider transaction Mar 29, 2024 Mar 29, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
144 Notice of proposed sale Feb 14, 2024 —
144 Notice of proposed sale Feb 14, 2024 —
144 Notice of proposed sale Feb 13, 2024 —
144 Notice of proposed sale Feb 13, 2024 —
144 Notice of proposed sale Feb 13, 2024 —
144 Notice of proposed sale Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Feb 12, 2024 Feb 8, 2024
SC 13G Ownership over 5% (passive) Feb 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
4 Insider transaction Jan 18, 2024 Jan 16, 2024
144 Notice of proposed sale Jan 16, 2024 —
4 Insider transaction Jan 12, 2024 Jan 10, 2024
4 Insider transaction Jan 11, 2024 Jan 9, 2024
144 Notice of proposed sale Jan 10, 2024 —
4 Insider transaction Jan 9, 2024 Jan 5, 2024
4 Insider transaction Jan 9, 2024 Jan 5, 2024
4 Insider transaction Jan 9, 2024 Jan 5, 2024
4 Insider transaction Jan 9, 2024 Jan 5, 2024
144 Notice of proposed sale Jan 9, 2024 —
144 Notice of proposed sale Jan 5, 2024 —
144 Notice of proposed sale Jan 5, 2024 —
144 Notice of proposed sale Jan 5, 2024 —
144 Notice of proposed sale Jan 5, 2024 —
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Dec 18, 2023 Dec 15, 2023
4 Insider transaction Nov 16, 2023 Nov 15, 2023
4 Insider transaction Oct 18, 2023 Oct 16, 2023
144 Notice of proposed sale Oct 16, 2023 —
144 Notice of proposed sale Oct 11, 2023 —
144 Notice of proposed sale Oct 5, 2023 —
4 Insider transaction Sep 19, 2023 Sep 15, 2023
144 Notice of proposed sale Sep 15, 2023 —
4 Insider transaction Aug 25, 2023 Aug 23, 2023
4 Insider transaction Aug 25, 2023 Aug 23, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
144 Notice of proposed sale Aug 23, 2023 —
144 Notice of proposed sale Aug 23, 2023 —
144 Notice of proposed sale Aug 21, 2023 —
144 Notice of proposed sale Aug 21, 2023 —
144 Notice of proposed sale Aug 21, 2023 —
144 Notice of proposed sale Aug 21, 2023 —
4 Insider transaction Aug 17, 2023 Aug 15, 2023
4 Insider transaction Aug 16, 2023 Aug 14, 2023
4 Insider transaction Aug 16, 2023 Aug 14, 2023
144 Notice of proposed sale Aug 15, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
DNLI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1714899

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.